Abstract
Purpose
OSA-COPD overlap is an important and prevalent condition yet remains under-recognised among the vast majority of respiratory health professionals. Patients with OSA-COPD overlap experience more severe respiratory symptoms and worse quality of life, and the relative risk of exacerbations, hospitalisations, and mortality is higher than in either disease state alone.
Methods
Electronic databases PUBMED and Google Scholar were searched for studies and academic papers that discussed OSA-COPD overlap. Relevant papers that discussed prevalence, pathophysiology, microbiome studies, treatment regimens and outcomes were included in this paper.
Results
High-risk patients with either COPD or OSA should be screened for overlap syndrome as part of routine clinical practice. Screening questionnaires can identify high-risk patients with COPD who may benefit from formal polysomnography. Patients with OSA who are aged over 40 with a significant smoking history or environmental exposures have an increased pre-test probability of obstructive airway disease. The potential roles of gastro-oesophageal reflux disease and lung-gut microbiome are evolving and merit further investigation. A tailored approach to reach a timely diagnosis and thus optimisation of both conditions are key to management. CPAP is the primary therapy for OSA; however, patients with more advanced COPD, with daytime hypercapnia or severe nocturnal desaturations, may benefit from bilevel positive airway pressure.
Conclusion
Increased awareness, access to timely investigations and initiation of therapy will improve overall outcomes in OSA-COPD overlap by reducing hospitalisations for exacerbations of COPD and improve mortality rates.
Similar content being viewed by others
Availability of data and material
All study references are freely available on electronic databases.
Code availability
Not applicable.
References
Fenley DC (1985) Sleep in chronic obstructive lung disease. Clin Chest Med 6:651–661
Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C et al (2007) Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532–555
Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL (2007) International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370(9589):741–750
Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC, Hamilton GS, Dharmage SC (2017) Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev 34:70–81
Dorsch JJ, Wickwire EM (2019) OSA/COPD overlap: convergence on a theme? J Clin Sleep Med 15(1):9–10
Shawon MS, Perret JL, Senaratna CV, Lodge C, Hamilton GS, Dharmage SC (2017) Current evidence on prevalence and clinical outcomes of co-morbid obstructive sleep apnea and chronic obstructive pulmonary disease: a systematic review. Sleep Med Rev 32:58–68
Shaya FT, Lin PJ, Aljawadi MH, Scharf SM (2009) Elevated economic burden in obstructive lung disease patients with concomitant sleep apnea syndrome. Sleep Breath 13(4):317–323
Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R (1995) Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med 151(1):82–86
Rizzi M, Palma P, Andreoli A, Greco M, Bamberga M, Antivalle M et al (1997) Prevalence and clinical feature of the “overlap syndrome”, obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), in OSA population. Sleep Breath 2:68–72
Chokhani R, Pathak V, Kanth R (2005) Sleep apnoea syndrome in Nepal. Nepal Med Coll J 7:32–35
O'Brien A, Whitman K (2005) Lack of benefit of continuous positive airway pressure on lung function in patients with overlap syndrome. Lung 183:389–404
Lopez-Acevedo MN, Torres-Palacios A, Elena Ocasio-Tascon M, Campos-Santiago Z, Rodriguez-Cintron W (2009) Overlap syndrome: an indication for sleep studies? : a pilot study. Sleep Breath 13:409–413
Shiina K, Tomiyama H, Takata Y, Yoshida M, Kato K, Nishihata Y et al (2012) Overlap syndrome: additive effects of COPD on the cardiovascular damages in patients with OSA. Respir Med 106:1335–1341
Greenberg-Dotan S, Reuveni H, Tal A, Oksenberg A, Cohen A, Shaya FT et al (2014) Increased prevalence of obstructive lung disease in patients with obstructive sleep apnea. Sleep Breath 18:69–75
Larsson LG, Lindberg A, Franklin KA, Lundbäck B (2001) Obstructive sleep apnoea syndrome is common in subjects with chronic bronchitis. Respiration. 68(3):250–255
Sanders MH, Newman AB, Haggerty CL, Redline S, Lebowitz M, Samet J, O'Connor GT, Punjabi NM, Shahar E (2003) Sleep Heart Health Study. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med 167:7–14
Perimenis P, Karkoulias K, Konstantinopoulos A, Alchanatis M, Perimeni PP, Athanasopoulos A, Spyropoulos K (2007) The impact of long-term conventional treatment for overlap syndrome (obstructive sleep apnea and chronic obstructive pulmonary disease) on concurrent erectile dysfunction. Respir Med 101(2):210–216
Machado ML, Vollmer WM, Togeiro SM, Bilderback AL, Oliveira MC, Leitão FS, Queiroga F, Lorenzi-Filho G, Krishnan JA (2010) CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J 35(1):132–137
Diomidous M, Marios N, Zikos D, Konstantinos G, Zoe D, Mpizopoulou Z et al (2012) The syndrome of sleep apnea in the elderly suffering from COPD and live in the county of Attica. Greece Mater Sociomed 24:227–231
Kumar R, Nagar D, Mallick A, Kumar M, Tarke CR, Goel N (2013) Obstructive sleep apnoea and atopy among middle aged chronic obstructive pulmonary disease and bronchial asthma patients. J Assoc Physicians India 61:615–618
Steveling EH, Clarenbach CF, Miedinger D, Enz C, Dürr S, Maier S, Sievi N, Zogg S, Leuppi JD, Kohler M (2014) Predictors of the overlap syndrome and its association with comorbidities in patients with chronic obstructive pulmonary disease. Respiration. 88(6):451–457
Turcani P, Skrickova J, Pavlik T, Janousova E, Orban M (2014) The prevalence of obstructive sleep apnea in patients hospitalized for COPD exacerbation. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 159(3):422–428
Venkateswaran S, Tee A (2014) Overlap syndrome between chronic obstructive pulmonary disease and obstructive sleep apnoea in a Southeast Asian teaching hospital. Singap Med J 55(9):488
Soler X, Gaio E (2015) High prevalence of obstructive sleep apnea in patients with moderate to severe chronic obstructive pulmonary disease. Ann Am Thorac Soc 12:1219–1225
Krachman SL, Tiwari R, Vega ME, Yu D, Soler X, Jaffe F, Kim V, Swift I, D’Alonzo GE, Criner GJ (2016) Effect of emphysema severity on the apnea–hypopnea index in smokers with obstructive sleep apnea. Ann Am Thorac Soc 13(7):1129–1135
Orr JE, Schmickl CN, Edwards BA, DeYoung PN, Brena R, Sun XS, Jain S, Malhotra A, Owens RL (2020) Pathogenesis of obstructive sleep apnea in individuals with the COPD+ OSA Overlap syndrome versus OSA alone. Phys Rep 8(3):e14371
Kim V, Han MK, Vance GB, Make BJ, Newell JD, Hokanson JE, Hersh CP, Stinson D, Silverman EK, Criner GJ (2011) COPDGene Investigators. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest. 140(3):626–633
McNicholas WT (2000) Impact of sleep in COPD. Chest 117:48S–53S
McSharry DG, Ryan S, Calverley P et al (2012) Sleep quality in chronic obstructive pulmonary disease. Respirology 17:1119–1124
Agusti A, Hedner J, Marin JM et al (2011) Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev 20:183–194
Deegan PC, McNicholas WT (1995) Pathophysiology of obstructive sleep apnoea. Eur Respir J 8:1161–1178
Wang Y, Hu K, Liu K, Li Z, Yang J, Dong Y, Nie M, Chen J, Ruan Y, Kang J (2015) Obstructive sleep apnea exacerbates airway inflammation in patients with chronic obstructive pulmonary disease. Sleep Med 16:1123–1130
Owens RL, Macrea MM, Teodorescu M (2017) The overlaps of asthma or COPD with OSA: a focused review. Respirology. 22(6):1073–1083
Rodriguez-Roisin R (2000) Toward a consensus definition for COPD exacerbations. Chest. 117(5):398S–401S
Wedzicha JA, Seemungal TA (2007) COPD exacerbations: defining their cause and prevention. Lancet 370(9589):786–796
Groenewegen KH, Schols AM, Wouters EF (2003) Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 124(2):459–467
Tan WC (2004) Factors associated with outcomes of acute exacerbations of chronic obstructive pulmonary disease. COPD: J Chron Obstruct Pulmon Dis 1(2):225–247
Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 60(11):925–931
Matkovic Z, Huerta A, Soler N et al (2012) Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration. 84(1):17–26
Naranjo M, Willes L, Prillaman BA, Quan SF, Sharma S (2020) Undiagnosed OSA may significantly affect outcomes in adults admitted for COPD in an inner-city hospital. Chest. 158(3):1198–1207
Jaoude P, El-Solh AA (2019) Predictive factors for COPD exacerbations and mortality in patients with overlap syndrome. Clin Respir J 13(10):643–651
Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR (2010) Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 182(3):325–331
Durgan DJ, Ganesh BP, Cope JL, Ajami NJ, Phillips SC, Petrosino JF, Hollister EB, Bryan RM Jr (2016) Role of the gut microbiome in obstructive sleep apnea–induced hypertension. Hypertension. 67(2):469–474
Xu H, Li X, Zheng X, Xia Y, Fu Y, Li X, Qian Y, Zou J, Zhao A, Guan J, Gu M (2018) Pediatric obstructive sleep apnea is associated with changes in the oral microbiome and urinary metabolomics profile: a pilot study. J Clin Sleep Med 14(9):1559–1567
Badran M, Mashaqi S, Gozal D (2020) The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea. Expert Opin Ther Targets 24(12):1263–1282
Niewoehner DE, Collins (2000) D, Erbland ML. Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. Am J Respir Crit Care Med 161(4 Pt 1):1201–1205
Zider AD, Wang X, Buhr RG, Sirichana W, Barjaktarevic IZ, Cooper CB (2017) Reduced COPD exacerbation risk correlates with improved FEV1: a meta-regression analysis. Chest. 152(3):494–501
Schönmann M, Sievi NA, Clarenbach CF et al (2015) Physical activity and the frequency of acute exacerbations in patients with chronic obstructive pulmonary disease. Lung. 193(1):63–70
Miravitlles M, Guerrero T, Mayordomo C, Sanchez-Agudo L, Nicolau F, Segu JL (2000) Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. EOLO Stud Group Respir 67(5):495–501
Resta O, Foschino Barbaro MP, Brindicci C, Nocerino MC, Caratozzolo G, Carbonara M (2002) Hypercapnia in overlap syndrome: possible determinant factors. Sleep Breath 6:11–18
Chaouat A, Weitzenblum E, Krieger J et al (1999) Prognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAP. Eur Respir J 13(5):1091–1096
Mermigkis C, Kopanakis A, Foldvary-Schaefer N et al (2007) Health-related quality of life in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease (overlap syndrome). Int J Clin Pract 61(2):207–211
Zohal MA, Yazdi Z, Kazemifar AM, Mahjoob P, Ziaeeha M (2014) Sleep quality and quality of life in COPD patients with and without suspected obstructive sleep apnea. Sleep Disord 2014:508372
He BT, Lu G, Xiao SC et al (2017) Coexistence of OSA may compensate for sleep related reduction in neural respiratory drive in patients with COPD. Thorax. 72(3):256–262
Donovan LM, Feemster LC, Udris EM, Griffith MF, Spece LJ, Palen BN, He K, Parthasarathy S, Strohl KP, Kapur VK, Au DH (2019) Poor outcomes among patients with chronic obstructive pulmonary disease with higher risk for undiagnosed obstructive sleep apnea in the LOTT cohort. J Clin Sleep Med 15(1):71–77
Sharma B, Neilan TG, Kwong RY et al (2013) Evaluation of right ventricular remodeling using cardiac magnetic resonance imaging in co-existent chronic obstructive pulmonary disease and obstructive sleep apnea. COPD. 10(1):4–10
Neilan TG, Bakker JP, Sharma B et al (2014) T1 measurements for detection of expansion of the myocardial extracellular volume in chronic obstructive pulmonary disease. Can J Cardiol 30(12):1668–1675
Du W, Liu J, Zhou J, Ye D, OuYang Y, Deng Q (2018) Obstructive sleep apnea, COPD, the overlap syndrome, and mortality: results from the 2005–2008 National Health and Nutrition Examination Survey. Int J Chron Obstructive Pulm Dis 13:665
Lavie P, Herer P, Lavie L (2007) Mortality risk factors in sleep apnoea: a matched case–control study. J Sleep Res 16(1):128–134
Stanchina ML, Welicky LM, Donat W, Lee D, Corrao W, Malhotra A (2013) Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome. J Clin Sleep Med 9(8):767–772
Singh G, Agarwal A, Zhang W, Kuo YF, Sultana R, Sharma G (2019) Impact of PAP therapy on hospitalization rates in Medicare beneficiaries with COPD and coexisting OSA. Sleep Breath 23(1):193–200
Konikkara J, Tavella R, Willes L, Kavuru M, Sharma S (2016) Early recognition of obstructive sleep apnea in patients hospitalized with COPD exacerbation is associated with reduced readmission. Hosp Pract 44(1):41–47
Faria AC, da Costa CH, Rufino R (2015) Sleep Apnea Clinical Score, Berlin Questionnaire, or Epworth Sleepiness Scale: which is the best obstructive sleep apnea predictor in patients with COPD? Int J Gen Med 8:275
Soler X, Liao SY, Marin JM, Lorenzi-Filho G, Jen R, DeYoung P, Owens RL, Ries AL, Malhotra A (2017) Age, gender, neck circumference, and Epworth sleepiness scale do not predict obstructive sleep apnea (OSA) in moderate to severe chronic obstructive pulmonary disease (COPD): the challenge to predict OSA in advanced COPD. PLoS One 12(5):e0177289
McNicholas WT (2016) Chronic obstructive pulmonary disease and obstructive sleep apnoea—the overlap syndrome. J Thorac Dis 8(2):236
Tamanna S, Campbell D, Warren R, Ullah MI (2016) Effect of CPAP therapy on symptoms of nocturnal gastroesophageal reflux among patients with obstructive sleep apnea. J Clin Sleep Med 12(9):1257–1261
Benson VS, Müllerová H, Vestbo J, Wedzicha JA, Patel A, Hurst JR (2015) Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease. Respir Med 109(9):1147–1154
Patel AR, Hurst IR (2013) Gastro-oesophageal reflux disease and COPD. COPD and Comorbidity (ERS Monograph). Sheffield. Eur Respir Soc 18:105–116
Hesselbacher S, Subramanian S, Rao S, Casturi L, Surani S (2014) Self-reported sleep bruxism and nocturnal gastroesophageal reflux disease in patients with obstructive sleep apnea: relationship to gender and ethnicity. Open Respir Med J 8:34
de Miguel J, Cabello J, Sanchez-Alarcos JM, Alvarez-Sala R, Espinos D, Alvarez-Sala JL (2002) Long-term effects of treatment with nasal continuous positive airway pressure on lung function in patients with overlap syndrome. Sleep Breath 6(1):3–10
Toraldo DM, De Nuccio F, Nicolardi G (2010) Fixed-pressure nCPAP in patients with obstructive sleep apnea (OSA) syndrome and chronic obstructive pulmonary disease (COPD): a 24-month follow-up study. Sleep Breath 14(2):115–123
Alford NJ, Fletcher EC, Nickeson D (1986) Acute oxygen in patients with sleep apnea and COPD. Chest 89:30–38
Köhnlein T, Windisch W, Köhler D, Drabik A, Geiseler J, Hartl S, Karg O, Laier-Groeneveld G, Nava S, Schönhofer B et al (2014) Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicenter, randomized, controlled clinical trial. Lancet Respir Med 2:698–705
Kuklisova Z, Tkacova R, Joppa P, Wouters E, Sastry M (2017) Severity of nocturnal hypoxia and daytime hypercapnia predicts CPAP failure in patients with COPD and obstructive sleep apnea overlap syndrome. Sleep Med 30:139–145
Author information
Authors and Affiliations
Contributions
MB wrote the first draft of the manuscript and all subsequent drafts. RR was responsible for the original concept and reviewed and edited all drafts. MMD, SW and FG reviewed all drafts of the manuscript.
Corresponding author
Ethics declarations
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Brennan, M., McDonnell, M.J., Walsh, S.M. et al. Review of the prevalence, pathogenesis and management of OSA-COPD overlap. Sleep Breath 26, 1551–1560 (2022). https://doi.org/10.1007/s11325-021-02540-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-021-02540-8